Argentina vs Australia: Proportion of isolates with decreased susceptibility or resistance
Argentina
0
in 2020
Australia
0.01
in 2020
Argentina rank
13th
Australia rank
12th
Proportion of isolates with decreased susceptibility or resistance over time
- Argentina
- Australia
How they compare
Australia currently reports 0.01 against 0 in Argentina, a difference of 0.01.
Across all 11 years both countries report, Australia has been ahead every year.
Argentina ranks 13th and Australia ranks 12th of 52 countries.
Australia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Argentina | Australia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0.0317 | 0.0317 | Australia |
| 2010s | 0.0164 | 0.4001 | 0.3837 | Australia |
| 2020s | 0 | 0.01 | 0.01 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Argentina or Australia?
- Australia, at 0.01 against 0 in Argentina as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Argentina and Australia?
- 0.01, with Australia ahead.
- How many years of comparable data are there for Argentina and Australia?
- 11 years are reported by both, from 2009 to 2020.
- How do Argentina and Australia rank globally for proportion of isolates with decreased susceptibility or resistance?
- Argentina ranks 13th and Australia ranks 12th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.